Home » Topics » BioWorld Science

BioWorld Science
RSS

Studies explore asprosin as a target for treating binge eating

June 20, 2022

RP Scherer Technologies patents TROP-2-targeting antibody-drug conjugates

June 20, 2022

Anti-glypican-3 antibody-drug conjugates developed at Ardeagen

June 20, 2022

2692372 Ontario, Dunad Therapeutics patent tubulin polymerization inhibitors

June 20, 2022

Chengdu Baiyu Pharmaceutical describes G12C mutant GTPase KRAS inhibitors

June 20, 2022

New MRGPRX2 antagonists identified at Bioardis

June 20, 2022

Novel humanized mouse model of posterior fossa A ependymoma

June 20, 2022

Magmas inhibition as new therapeutic strategy in medulloblastoma

June 20, 2022

CD47 blockade with 225Ac-anti-CD33 radioimmunoconjugate in acute myeloid leukemia

June 20, 2022

Alpha-emitting radioimmunotherapy: using throrium-227 and antibody conjugates

June 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...